Universidad Peruana Cayetano Heredia

Listar Artículos en revistas indizadas por autor "Arana, Byron"

Listar Artículos en revistas indizadas por autor "Arana, Byron"

Ordenar por:Orden:Resultados:

  • Castro, Maria Del Mar; Rode, Joelle; Machado, Paulo R L; Llanos Cuentas, Elmer Alejandro; Hueb, Marcia; Cota, Glaucia; Rojas, Isis Valentina; Orobio, Yenifer; Oviedo Sarmiento, Oscar; Rojas, Ernesto; Quintero, Juliana; Pimentel, Maria Ines Fernandes; Soto, Jaime; Suprien, Carvel; Alvarez Romero, Fiorela Yuli; Ramos Ttito, Ana Pilar; Arantes, Rayssa Basilio Dos Santos; da Silva, Rosiana Estefane; Arenas, Claudia Marcela; Vélez, Ivan Dario; Lyra, Marcelo Rosandiski; Saravia, Nancy Gore; Arana, Byron; Alexander, Neal (Public Library of Science, 2023)
    BACKGROUND: Treatment guidance for children and older adult patients affected by cutaneous leishmaniasis (CL) is unclear due to limited representation of these groups in clinical trials.METHODS: We conducted a collaborative ...
  • Olliaro, Piero; Grogl, Max; Boni, Marina; Carvalho, Edgar M.; Chebli, Houda; Cisse, Mamoudou; Diro, Ermias; Cota, Gláucia Fernandes; Erber, Astrid C.; Gadisa, Endalamaw; Handjani, Farhad; Khamesipour, Ali; Llanos Cuentas, Elmer Alejandro; Carvajal, Liliana López; Grout, Lise; Lmimouni, Badre Eddine; Mokni, Mourad; Nahzat, Mohammad Sami; Salah, Afif Ben; Ozbel, Yusuf; Pascale, Juan Miguel; Molina, Nidia Rizzo; Rode, Joelle; Romero, Gustavo; Ruiz-Postigo, José Antonio; Saravia, Nancy Gore; Soto, Jaime; Uzun, Soner; Mashayekhi, Vahid; Vélez, Ivan Dario; Vogt, Florian; Zerpa, Olga; Arana, Byron (Public Library of Science, 2018)
    Introduction: Progress with the treatment of cutaneous leishmaniasis (CL) has been hampered by inconsistent methodologies used to assess treatment effects. A sizable number of trials conducted over the years has generated ...
  • Erber, Astrid Christine; Arana, Byron; Bennis, Issam; Ben Salah, Afif; Boukthir, Aicha; Castro Noriega, Maria Del Mar; Cissé, Mamoudou; Cota, Gláucia Fernandes; Handjani, Farhad; Kebede, Mairie Guizaw; Lang, Trudie; López Carvajal, Liliana; Marsh, Kevin; Martinez Medina, Dalila; Plugge, Emma; Olliaro, Piero (BMJ Publishing Group, 2018)
    INTRODUCTION: Lack of investments in drug development, lack of standardisation of clinical trials and the complexity of disease presentations contribute to the current lack of effective, safe and adapted treatments for ...
  • Erber, Astrid C.; Arana, Byron; Ben Salah, Afif; Bennis, Issam; Boukthir, Aicha; Castro Noriega, María Del Mar; Cissé, Mamoudou; Cota, Gláucia Fernandes; Handjani, Farhad; López-Carvajal, Liliana; Marsh, Kevin; Medina, Dalila Martínez; Plugge, Emma; Lang, Trudie; Olliaro, Piero (Public Library of Science, 2020)
    BACKGROUND: Cutaneous leishmaniasis (CL) is a disease that often affects exposed skin areas and may heal leaving lifelong scars. Patients' expectations from treatment are rarely considered in drug development for CL. An ...
  • Lopez, Liliana; Alvarez, Fiorela; Ramos, Ana Pilar; Llanos Cuentas, Elmer Alejandro; Echevarria Zarate, Juan Ignacio; Velez, Ivan; Boni, Marina; Rode, Joelle; Quintero, Juliana; Jimenez, Alejandra; Tabares, Yulied; Mendez, Claudia; Arana, Byron (Public Library of Science, 2022)
    Background: Systemic pentavalent antimonials, mainly meglumine antimoniate, continue to be the first-choice drugs for treatment of cutaneous leishmaniasis (CL) despite their toxicity, difficulty of administration and high ...

Buscar en el Repositorio


Listar

Panel de Control